Adjunctive simvastatin provided no benefit in multiple sclerosis patients taking intramuscular interferon beta-1a (Avonex), results of a new study showed.
"The study gave a clear result that simvastatin cannot be recommended as an add-on therapy for intramuscular interferon beta-1A," according to Per Soelberg Sorensen, MD, of Copenhagen University Hospital in Denmark.
But while simvastatin offered no additional disease control compared with placebo, it was safe, Soelberg Sorensen said at the European Committee for Treatment and Research in Multiple Sclerosis meeting.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1319